Prime Medicine, Inc. (PRME) EBITDA
- 2026-06-30: Basis Reported; EBITDA -$41.5M; Operating income (m); Depreciation and amortization (m).
- 2026-03-31: Basis Reported; EBITDA -$48.8M; Operating income (m); Depreciation and amortization (m).
- 2025-12-31: Basis Reported; EBITDA -$46.73M; Operating income (m); Depreciation and amortization (m).
- 2025-09-30: Basis Reported; EBITDA -$52.09M; Operating income (m); Depreciation and amortization (m).
Complete source-backed ebitda history.
- Available history
- 2020-12-31 to 2026-06-30
- Data captured
Historical EBITDA
EBITDA 3 month
| Date | Basis | EBITDA | Operating income | Depreciation and amortization | Revenue | EBITDA margin | Capital spending | Operating cash flow | Cost of products and services | Research and development | Selling, general and administration | Income tax expense / benefit |
|---|
| 2026-06-30 | Reported | -$41.5M | (m) | (m) | (m) | (m) | $46.00K* | -$41.05M* | (m) | $33.40M | (m) | (m) |
|---|
| 2026-03-31 | Reported | -$48.8M | (m) | (m) | (m) | (m) | $214.00K | -$42.71M | (m) | $34.10M | (m) | (m) |
|---|
| 2025-12-31 | Reported | -$46.73M | (m) | (m) | (m) | -5576.61% | (m) | (m) | (m) | (m) | (m) | (m) |
|---|
| 2025-09-30 | Reported | -$52.09M | (m) | (m) | (m) | -4252.41% | $247.00K* | -$35.04M* | (m) | $43.99M | (m) | (m) |
|---|
| 2025-06-30 | Reported | -$51.51M | (m) | (m) | (m) | -4620.00% | $1.57M* | -$41.41M* | (m) | $41.38M | (m) | $0.00 |
|---|
| 2025-03-31 | Reported | -$50.69M | (m) | (m) | (m) | -3486.38% | $2.42M | -$48.86M | (m) | $40.56M | (m) | $0.00 |
|---|
| 2024-12-31 | Reported | -$42.51M | (m) | (m) | (m) | -1947.09% | (m) | (m) | (m) | (m) | (m) | (m) |
|---|
| 2024-09-30 | Reported | -$52.67M | (m) | (m) | (m) | -25202.87% | $1.28M* | -$25.91M* | (m) | $40.34M | (m) | $0.00 |
|---|
| 2024-06-30 | Reported | -$54.13M | (m) | (m) | (m) | (m) | $1.90M* | -$45.49M* | (m) | $43.07M | (m) | -$134.00K |
|---|
| 2024-03-31 | Reported | -$47.03M | (m) | (m) | (m) | -7957.02% | $2.32M | -$67.71M | (m) | $37.77M | (m) | $134.00K |
|---|
| 2023-12-31 | Reported | -$66.8M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
|---|
| 2023-09-30 | Reported | -$50.22M | (m) | (m) | (m) | (m) | $2.91M* | -$39.17M* | (m) | $40.97M | (m) | -$108.00K |
|---|
| 2023-06-30 | Reported | -$44.14M | (m) | (m) | (m) | (m) | $1.98M* | -$40.82M* | (m) | $34.60M | (m) | $31.00K |
|---|
| 2023-03-31 | Reported | -$38.98M | (m) | (m) | (m) | (m) | $2.00M | -$41.56M | (m) | $30.88M | (m) | -$202.00K |
|---|
| 2022-12-31 | Reported | -$37.82M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
|---|
| 2022-09-30 | Reported | -$31.02M | (m) | (m) | (m) | (m) | $4.79M* | -$30.10M* | (m) | $25.05M | (m) | $212.00K |
|---|
| 2022-06-30 | Reported | -$25.88M | (m) | (m) | (m) | (m) | $4.80M* | -$20.22M* | (m) | (m) | (m) | -$442.00K |
|---|
| 2022-03-31 | Reported | -$19.61M | (m) | (m) | (m) | (m) | $1.69M | -$50.79M | (m) | $13.68M | (m) | -$532.00K |
|---|
| 2021-12-31 | Reported | -$59.85M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
|---|
| 2021-09-30 | Reported | -$10.23M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $7.40M | (m) | -$2.37M |
|---|
EBITDA 12 month
| Date | Basis | EBITDA | Operating income | Depreciation and amortization | Revenue | EBITDA margin | Capital spending | Operating cash flow | Cost of products and services | Research and development | Selling, general and administration | Income tax expense / benefit |
|---|
| 2025-12-31 | Reported | -$201.03M | (m) | (m) | (m) | -4340.00% | $4.53M | -$162.56M | (m) | $160.64M | (m) | $0.00 |
|---|
| 2024-12-31 | Reported | -$196.34M | (m) | (m) | (m) | -6581.93% | $7.29M | -$122.86M | (m) | $155.29M | (m) | $0.00 |
|---|
| 2023-12-31 | Reported | -$200.14M | (m) | (m) | (m) | (m) | $8.72M | -$165.41M | (m) | $147.91M | (m) | -$279.00K |
|---|
| 2022-12-31 | Reported | -$114.32M | (m) | (m) | (m) | (m) | $16.09M | -$131.83M | (m) | $86.72M | (m) | -$948.00K |
|---|
| 2021-12-31 | Reported | -$83.91M | (m) | (m) | (m) | (m) | $4.15M | -$34.08M | (m) | $70.55M | (m) | -$486.00K |
|---|
| 2020-12-31 | Reported | -$889,000.00 | (m) | (m) | (m) | -17.06% | $639.00K | -$5.54M | (m) | $2.98M | (m) | $1.87M |
|---|